Subtypes of functional alpha1-adrenoceptor.

James R Docherty
Author Information
  1. James R Docherty: Department of Physiology, Royal College of Surgeons in Ireland, 123, St. Stephen's Green, Dublin 2, Ireland. docherty@rcsi.ie

Abstract

In this review, subtypes of functional alpha1-adrenoceptor are discussed. These are cell membrane receptors, belonging to the seven-transmembrane-spanning G-protein-linked family of receptors, which respond to the physiological agonist noradrenaline. alpha1-Adrenoceptors can be divided into alpha1A-, alpha1B- and alpha1D-adrenoceptors, all of which mediate contractile responses involving Gq/11 and inositol phosphate turnover. A fourth alpha1-adrenoceptor, the alpha1L-, represents a functional phenotype of the alpha1A-adrenoceptor. alpha1-Adrenoceptor subtype knock-out mice have refined our knowledge of the functions of alpha-adrenoceptor subtypes, particuarly as subtype-selective agonists and antagonists are not available for all subtypes. alpha1-Adrenoceptors function as stimulatory receptors involved particularly in smooth muscle contraction, especially contraction of vascular smooth muscle, both in local vasoconstriction and in the control of blood pressure and temperature, and contraction of the prostate and bladder neck. Central actions are now being elucidated.

References

  1. Mol Pharmacol. 1991 Dec;40(6):876-83 [PMID: 1661838]
  2. J Comp Neurol. 2004 Oct 4;478(1):1-10 [PMID: 15334645]
  3. J Pharmacol Exp Ther. 2003 Jun;305(3):1045-53 [PMID: 12649302]
  4. Br J Pharmacol. 2008 Sep;155(1):110-7 [PMID: 18516067]
  5. Clin Exp Pharmacol Physiol. 2007 Sep;34(9):884-8 [PMID: 17645635]
  6. J Pharmacol Exp Ther. 2007 Jul;322(1):214-21 [PMID: 17405867]
  7. Br J Pharmacol. 2008 Feb;153(3):591-7 [PMID: 18037913]
  8. J Comp Neurol. 2006 Jul 10;497(2):209-22 [PMID: 16705673]
  9. Br J Pharmacol. 1997 Jan;120(2):231-8 [PMID: 9117115]
  10. Prostate. 2006 May 15;66(7):761-7 [PMID: 16425183]
  11. J Smooth Muscle Res. 1999 Oct-Dec;35(5-6):181-92 [PMID: 10733154]
  12. Br J Clin Pharmacol. 1978 Sep;6(3):221-5 [PMID: 687500]
  13. Br J Pharmacol. 2009 Sep;158(1):259-66 [PMID: 19422394]
  14. J Pharmacol Exp Ther. 2005 Apr;313(1):16-23 [PMID: 15615865]
  15. J Neurosci. 1998 Jul 1;18(13):5086-94 [PMID: 9634574]
  16. Br J Pharmacol. 1997 Jan;120(2):247-58 [PMID: 9117117]
  17. Eur J Pharmacol. 1999 Apr 16;370(3):337-43 [PMID: 10334511]
  18. Br J Pharmacol. 2004 Jun;142(4):781-7 [PMID: 15205310]
  19. J Clin Invest. 2002 Mar;109(6):765-75 [PMID: 11901185]
  20. Am J Physiol. 1992 Jun;262(6 Pt 1):C1376-83 [PMID: 1616004]
  21. Eur J Pharmacol. 1997 Dec 4;340(1):45-52 [PMID: 9527505]
  22. Am J Physiol. 1995 Jan;268(1 Pt 2):H74-81 [PMID: 7840305]
  23. Eur J Pharmacol. 1993 Jul 20;238(2-3):407-10 [PMID: 7691623]
  24. Proc Natl Acad Sci U S A. 2002 Jul 9;99(14):9474-9 [PMID: 12093905]
  25. Eur J Pharmacol. 1997 Mar 19;322(2-3):225-7 [PMID: 9098691]
  26. Mol Pharmacol. 1996 Feb;49(2):209-15 [PMID: 8632751]
  27. Physiol Rev. 2003 Oct;83(4):1325-58 [PMID: 14506307]
  28. Rev Physiol Biochem Pharmacol. 1977;77:1-124 [PMID: 14389]
  29. Am J Physiol Heart Circ Physiol. 2007 Oct;293(4):H2140-7 [PMID: 17660397]
  30. Eur J Pharmacol. 1994 Nov 14;265(1-2):61-6 [PMID: 7883030]
  31. Eur J Pharmacol. 1997 Oct 1;336(1):37-42 [PMID: 9384252]
  32. Br J Pharmacol. 1995 Apr;114(8):1710-6 [PMID: 7599939]
  33. J Pharmacol Exp Ther. 1995 Jul;274(1):97-103 [PMID: 7616455]
  34. Br J Pharmacol. 1997 Dec;122(8):1541-50 [PMID: 9422797]
  35. Br J Pharmacol. 1995 Jul;115(5):781-6 [PMID: 8548177]
  36. Br J Pharmacol. 1996 Jul;118(5):1308-16 [PMID: 8818358]
  37. Proc Natl Acad Sci U S A. 1997 Oct 14;94(21):11589-94 [PMID: 9326654]
  38. Br J Pharmacol. 1997 Nov;122(5):825-32 [PMID: 9384497]
  39. J Pharmacol Exp Ther. 1988 Jul;246(1):359-70 [PMID: 2839669]
  40. Am J Physiol. 1948 Jun;153(3):586-600 [PMID: 18882199]
  41. Br J Pharmacol. 1997 Mar;120(5):819-26 [PMID: 9138687]
  42. Mol Pharmacol. 1999 Nov;56(5):858-66 [PMID: 10531388]
  43. Am J Physiol Heart Circ Physiol. 2005 Nov;289(5):H1923-32 [PMID: 15951348]
  44. J Clin Pharmacol. 1981 Nov-Dec;21(11):488-92 [PMID: 7037866]
  45. Biochim Biophys Acta. 1994 Apr 14;1212(1):26-42 [PMID: 8155724]
  46. J Urol. 2000 Aug;164(2):578-83 [PMID: 10893647]
  47. J Neurosci. 2006 Mar 22;26(12):3292-8 [PMID: 16554479]
  48. Mol Pharmacol. 2000 Apr;57(4):659-66 [PMID: 10727510]
  49. Can J Physiol Pharmacol. 2004 Oct;82(10):895-902 [PMID: 15573150]
  50. Br J Pharmacol. 1992 Nov;107(3):697-704 [PMID: 1361871]
  51. Cardiovasc Res. 2003 Dec 1;60(3):598-607 [PMID: 14659805]
  52. Naunyn Schmiedebergs Arch Pharmacol. 2008 Feb;376(6):397-406 [PMID: 18172615]
  53. Proc Natl Acad Sci U S A. 1988 Oct;85(19):7159-63 [PMID: 2845398]
  54. Br J Urol. 1998 Nov;82(5):733-7 [PMID: 9839591]
  55. Br J Pharmacol. 1996 Jul;118(6):1403-8 [PMID: 8832064]
  56. Eur J Pharmacol. 1998 Nov 13;361(1):1-15 [PMID: 9851536]
  57. Mol Pharmacol. 1986 Apr;29(4):321-30 [PMID: 3010073]
  58. Br J Pharmacol. 1997 Jul;121(6):1127-35 [PMID: 9249248]
  59. Auton Autacoid Pharmacol. 2008 Apr-Jul;28(2-3):81-5 [PMID: 18598289]
  60. Mol Pharmacol. 2005 Mar;67(3):912-22 [PMID: 15598970]
  61. J Cardiovasc Pharmacol. 1987 Apr;9(4):500-7 [PMID: 2438514]
  62. Fundam Clin Pharmacol. 1998;12(6):584-9 [PMID: 9818290]
  63. J Pharmacol Exp Ther. 2001 Mar;296(3):869-75 [PMID: 11181918]
  64. J Pharmacol Exp Ther. 1990 Aug;254(2):702-10 [PMID: 1974648]
  65. J Mol Signal. 2008 Feb 27;3:6 [PMID: 18304336]
  66. Pharmacol Rev. 1995 Jun;47(2):267-70 [PMID: 7568329]
  67. Br J Pharmacol. 1995 Jun;115(3):467-75 [PMID: 7582458]
  68. J Urol. 1986 Jul;136(1):1-4 [PMID: 2423716]
  69. J Biol Chem. 1990 May 15;265(14):8183-9 [PMID: 1970822]
  70. Br J Pharmacol. 2005 Feb;144(4):558-65 [PMID: 15655508]
  71. Eur J Pharmacol. 2008 Jan 14;578(2-3):349-58 [PMID: 17936747]
  72. Br J Pharmacol. 2005 Dec;146(7):942-51 [PMID: 16170328]
  73. Br J Clin Pharmacol. 1980 Apr;9(4):351-8 [PMID: 6155131]
  74. Eur J Pharmacol. 1996 Jan 4;295(1):69-73 [PMID: 8925876]
  75. Am J Physiol. 1990 Jan;258(1 Pt 2):R44-50 [PMID: 1967915]
  76. Br J Urol. 1994 Nov;74(5):572-8 [PMID: 7530120]
  77. J Pharmacol Exp Ther. 1998 Feb;284(2):576-85 [PMID: 9454800]
  78. Prog Brain Res. 2008;170:93-107 [PMID: 18655875]
  79. Eur J Pharmacol. 1990 Sep 21;186(2-3):273-8 [PMID: 1981186]
  80. Horm Metab Res. 2002 Sep;34(9):499-503 [PMID: 12384826]
  81. Br J Pharmacol. 1997 Nov;122(6):1009-14 [PMID: 9401762]
  82. Br J Pharmacol. 1995 Sep;116(1):1605-10 [PMID: 8564226]
  83. Eur J Pharmacol. 1996 Sep 12;311(2-3):187-98 [PMID: 8891599]
  84. Eur J Pharmacol. 2001 Mar;415(2-3):265-76 [PMID: 11275009]
  85. Nature. 2008 Mar 6;452(7183):93-7 [PMID: 18297054]
  86. Mol Pharmacol. 2003 Dec;64(6):1379-90 [PMID: 14645668]
  87. J Neurosci. 2005 Jan 5;25(1):173-83 [PMID: 15634779]
  88. Neuroscience. 2009 Feb 18;158(4):1616-24 [PMID: 19068225]
  89. J Urol. 1982 Oct;128(4):836-9 [PMID: 6183460]
  90. Br J Pharmacol. 1998 Jan;123(2):317-25 [PMID: 9489621]
  91. Mol Pharmacol. 2004 Aug;66(2):228-39 [PMID: 15266013]
  92. J Biol Chem. 1992 Dec 25;267(36):25798-802 [PMID: 1334487]
  93. Br J Pharmacol. 2008 Sep;155(1):103-9 [PMID: 18552869]
  94. Eur J Pharmacol. 2005 Oct 17;522(1-3):100-7 [PMID: 16213480]
  95. J Neurosci Res. 2005 Nov 15;82(4):571-9 [PMID: 16237725]
  96. Pharmacol Rev. 2001 Jun;53(2):319-56 [PMID: 11356987]
  97. Br J Pharmacol. 1996 Sep;119(1):158-64 [PMID: 8872369]
  98. Br J Pharmacol. 2007 Oct;152(3):332-40 [PMID: 17603545]
  99. J Clin Invest. 2003 Jun;111(11):1783-91 [PMID: 12782680]
  100. Br J Pharmacol. 2008 Apr;153(7):1485-94 [PMID: 18223667]
  101. Eur J Pharmacol. 1996 Mar 18;298(3):257-63 [PMID: 8846824]
  102. Br J Pharmacol. 1999 May;127(1):252-8 [PMID: 10369480]
  103. J Urol. 2005 Jul;174(1):370-4 [PMID: 15947692]
  104. Br J Pharmacol. 2005 Oct;146(3):456-66 [PMID: 16113694]
  105. Biochem Pharmacol. 1999 Sep 1;58(5):807-10 [PMID: 10449190]
  106. J Physiol. 1996 Oct 1;496 ( Pt 1):245-54 [PMID: 8910212]
  107. Pharmacol Ther. 1989;44(2):241-84 [PMID: 2577511]
  108. Br J Pharmacol. 2004 Nov;143(6):745-52 [PMID: 15451776]
  109. Br J Pharmacol. 1997 Nov;122(5):849-58 [PMID: 9384500]
  110. Biochem Pharmacol. 2007 Apr 15;73(8):1043-50 [PMID: 17011524]
  111. Br J Pharmacol. 1993 May;109(1):80-7 [PMID: 8098642]
  112. Br J Pharmacol. 1998 Apr;123(7):1359-66 [PMID: 9579731]
  113. Br J Pharmacol. 2005 Sep;146(2):306-12 [PMID: 15997230]
  114. Obes Res. 2004 Apr;12(4):612-20 [PMID: 15090628]
  115. Br J Pharmacol. 1999 Jul;127(6):1367-74 [PMID: 10455286]
  116. J Cardiovasc Pharmacol. 1994 Nov;24(5):745-52 [PMID: 7532752]
  117. Br J Pharmacol. 2002 May;136(1):127-35 [PMID: 11976277]
  118. Med Sci Sports Exerc. 2003 Aug;35(8):1316-9 [PMID: 12900684]
  119. J Pharmacol Exp Ther. 2003 Jun;305(3):1006-14 [PMID: 12626653]
  120. Int J Clin Pract. 2008 Oct;62(10):1547-59 [PMID: 18822025]
  121. Am J Physiol Heart Circ Physiol. 2002 Feb;282(2):H475-81 [PMID: 11788394]
  122. Nature. 1987 Sep 24-30;329(6137):333-5 [PMID: 2442626]
  123. Mol Pharmacol. 1993 Oct;44(4):784-95 [PMID: 8232229]
  124. J Biol Chem. 2001 Apr 27;276(17):13738-43 [PMID: 11278430]
  125. Auton Autacoid Pharmacol. 2005 Jul;25(3):101-3 [PMID: 15955029]
  126. Auton Autacoid Pharmacol. 2005 Oct;25(4):135-41 [PMID: 16176444]
  127. Am J Physiol Cell Physiol. 2005 Mar;288(3):C577-85 [PMID: 15496483]
  128. Br J Pharmacol. 2004 Jun;142(4):667-70 [PMID: 15159279]
  129. Br J Pharmacol. 1995 Aug;115(8):1399-406 [PMID: 8564198]
  130. Mol Pharmacol. 1993 Dec;44(6):1165-70 [PMID: 8264553]
  131. Eur J Pharmacol. 1998 Nov 13;361(1):79-83 [PMID: 9851544]
  132. Physiol Genomics. 2002;9(2):85-91 [PMID: 12006674]
  133. Eur J Pharmacol. 2006 Jul 1;540(1-3):155-61 [PMID: 16716294]
  134. Clin J Sport Med. 1997 Jul;7(3):168-73 [PMID: 9262882]
  135. Pharmacol Ther. 2008 Jun;118(3):359-71 [PMID: 18486226]
  136. J Pharmacol Exp Ther. 2006 Feb;316(2):733-42 [PMID: 16249372]
  137. Eur J Pharmacol. 1995 Jan 16;272(2-3):R5-6 [PMID: 7713154]
  138. Nat Med. 2000 Dec;6(12):1388-94 [PMID: 11100125]
  139. Br J Pharmacol. 2004 Jun;142(4):647-56 [PMID: 15159276]
  140. Br J Pharmacol. 1990 Jan;99(1):197-201 [PMID: 1970493]
  141. J Biol Chem. 1991 Apr 5;266(10):6365-9 [PMID: 1706716]
  142. Clin Exp Pharmacol Physiol Suppl. 1995 Dec;22(1):S88-90 [PMID: 9072456]
  143. Pharmacol Rev. 1988 Jun;40(2):87-119 [PMID: 2853370]
  144. Nature. 2000 Jan 6;403(6765):86-9 [PMID: 10638758]
  145. J Pharmacol Exp Ther. 1995 Dec;275(3):1583-9 [PMID: 8531132]

MeSH Term

Animals
Blood Pressure
Body Temperature Regulation
Drug Inverse Agonism
GTP-Binding Protein alpha Subunits, Gq-G11
Inositol Phosphates
Mice
Mice, Knockout
Muscle, Smooth
Muscle, Smooth, Vascular
Receptors, Adrenergic, alpha-1
Second Messenger Systems
Vasoconstriction

Chemicals

Inositol Phosphates
Receptors, Adrenergic, alpha-1
GTP-Binding Protein alpha Subunits, Gq-G11

Word Cloud

Created with Highcharts 10.0.0subtypesfunctionalalpha1-adrenoceptorreceptorscontractionalpha1-Adrenoceptorssmoothmusclereviewdiscussedcellmembranebelongingseven-transmembrane-spanningG-protein-linkedfamilyrespondphysiologicalagonistnoradrenalinecandividedalpha1A-alpha1B-alpha1D-adrenoceptorsmediatecontractileresponsesinvolvingGq/11inositolphosphateturnoverfourthalpha1L-representsphenotypealpha1A-adrenoceptoralpha1-Adrenoceptorsubtypeknock-outmicerefinedknowledgefunctionsalpha-adrenoceptorparticuarlysubtype-selectiveagonistsantagonistsavailablefunctionstimulatoryinvolvedparticularlyespeciallyvascularlocalvasoconstrictioncontrolbloodpressuretemperatureprostatebladderneckCentralactionsnowelucidatedSubtypes

Similar Articles

Cited By